Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Bempedoic Acid has a new mechanism of action compared to existing products. It is administered as a 180-mg dose, is approved by the US FDA and European Union for the treatment of hypercholesterolemia., Bempedoic Acid has a new mechanism of action compared to existing products. It is administered as a 180-mg dose, is approved by the US FDA and European Union for the treatment of hypercholesterolemia., , Read More